Search Results - Clemens Schulte

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-Switch study

    Clinical outcomes of high-risk patients with polycythemia vera after suboptimal response to first-line therapy who switched to ruxolitinib versus nonswitchers: results from the PV-... by Steffen Koschmieder, Clemens Schulte, Eyck von der Heyde, Lambert Busque, Françoise Boyer-Perrard, Timothy Devos, Francesco Passamonti, Wendy Y. Cheng, Mu Cheng, Marja Nuortti, Volker Baum, Claire Harrison

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    Feasibility of evaluating AI-enabled digital symptom monitoring in metastatic patients with NSCLC receiving pembrolizumab therapy: A German single-arm observational pilot study

    Feasibility of evaluating AI-enabled digital symptom monitoring in metastatic patients with NSCLC receiving pembrolizumab therapy: A German single-arm observational pilot study by Melissa L. Santorelli, Oliver Schmalz, Mathias Hoiczyk, David Heigener, Clemens Schulte, Markus Knott, Petra Hoffknecht, Joonas Vainio, Thomas Burke, Josephine M. Norquist, Sabine Riehl, Alexander Hildner, Lisa Barthuber, Sabine Bohnet

    Published 2025-07-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: